The ink was hardly dried on the paperwork for Thermo Fisher Scientific Inc.‘s deal to acquire German in-vitro diagnostics maker B.R.A.H.M.S. AG for roughly $470 million before the union’s first product hit the market.
Thermo Fisher Scientific
Thermo Fisher goes Down Under, buys out Biolab for $120 million
Laboratory instruments giant Thermo Fisher Scientific took a step toward shoring up some softness in its analytic technologies business with its $120 million acquisition of Australia-based Biolab.
The deal extends the Waltham-based firm’s reach into the antipodes, as Biolab has a significant presence in Australia and New Zealand.